Your institution may have access to this item. Find your institution then sign in to continue.
Title
Roche gobbles Smarticles.
Abstract
The article focuses on the acquisition of GeneWEAVE Bioscience firm by pharmaceutical firm Roche, for making an entry into the arena of microbiology diagnostics, and offers views of Steve Tablak, Chief Executive Officer (CEO) at GeneWEAVE, on the same.